Cytokinetics Inc. buy SVB Leerink LLC
Start price
26.02.26
/
50%
€53.50
Target price
26.02.27
€71.07
Performance (%)
21.94%
Price
08.05.26
€65.24
Summary
This prediction is currently active. The prediction currently has a performance of 21.94%. This prediction currently runs until 26.02.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 19.663% | 19.663% |
| iShares Core DAX® | 0.224% | 1.805% |
| iShares Nasdaq 100 | 6.047% | 15.716% |
| iShares Nikkei 225® | 5.724% | 12.343% |
| iShares S&P 500 | 2.172% | 7.723% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) had its price target raised by Leerink Partners from $83.00 to $84.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.80
15.08.23
15.08.23
€53.00
15.08.24
15.08.24
76.17%
16.08.24
16.08.24
